Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Treasury Shares (2023 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Treasury Shares for 3 consecutive years, with $7.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Treasury Shares rose 287.2% to $7.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $7.6 million, a 287.2% increase, with the full-year FY2024 number at $1.8 million, up 3246.93% from a year prior.
  • Treasury Shares was $7.6 million for Q3 2025 at 60 Degrees Pharmaceuticals, up from $2.1 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $7.6 million in Q3 2025 to a low of $52737.0 in Q4 2023.
  • A 3-year average of $1.8 million and a median of $1.3 million in 2024 define the central range for Treasury Shares.
  • Biggest YoY gain for Treasury Shares was 3246.93% in 2024; the steepest drop was 118.47% in 2024.
  • 60 Degrees Pharmaceuticals' Treasury Shares stood at $52737.0 in 2023, then surged by 3246.93% to $1.8 million in 2024, then soared by 329.87% to $7.6 million in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Treasury Shares are $7.6 million (Q3 2025), $2.1 million (Q2 2025), and $2.1 million (Q1 2025).